Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2016

01-07-2016 | Editorial

SEMS for Palliation of Malignant Colonic Obstruction: Why SEMi Available Is Not Good Enough

Author: Christian P. Selinger

Published in: Digestive Diseases and Sciences | Issue 7/2016

Login to get access

Excerpt

In the past, treatment for acute colonic obstruction was emergency surgery with ostomy. Over the last two decades, the availability of colonic self-expanding metal stents (SEMSs) has provided new treatment options and therapeutic paradigms for malignant obstruction of the colon. In the setting of incurable colorectal cancer (CRC) complicated by colonic obstruction, colonic SEMS placement is the preferred option for palliation of patients not receiving antiangiogenic therapy [1]. …
Literature
1.
go back to reference Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19:5565–5574.CrossRefPubMedPubMedCentral Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19:5565–5574.CrossRefPubMedPubMedCentral
2.
go back to reference Selinger CP, Ramesh J, Martin DF. Long-term success of colonic stent insertion is influenced by indication but not by length of stent or site of obstruction. Int J Colorectal Dis. 2011;26:215–218.CrossRefPubMed Selinger CP, Ramesh J, Martin DF. Long-term success of colonic stent insertion is influenced by indication but not by length of stent or site of obstruction. Int J Colorectal Dis. 2011;26:215–218.CrossRefPubMed
3.
go back to reference Okafor PN, Stobaugh DJ, Song LMWK, Limburg PJ, Talwalkar JA. Socioeconomic inequalities in the utilization of colorectal stens for the treatment of malignant bowel obstruction. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-015-4019-8 Okafor PN, Stobaugh DJ, Song LMWK, Limburg PJ, Talwalkar JA. Socioeconomic inequalities in the utilization of colorectal stens for the treatment of malignant bowel obstruction. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-015-4019-8
4.
go back to reference Patkar V, Acosta D, Davidson T, Jones A, Fox J, Keshtgar M. Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer. 2011;2011:831605.CrossRefPubMedPubMedCentral Patkar V, Acosta D, Davidson T, Jones A, Fox J, Keshtgar M. Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer. 2011;2011:831605.CrossRefPubMedPubMedCentral
5.
go back to reference Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351–357.CrossRefPubMedPubMedCentral Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351–357.CrossRefPubMedPubMedCentral
6.
go back to reference Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol. 2012;30:401–405.CrossRefPubMed Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol. 2012;30:401–405.CrossRefPubMed
7.
go back to reference Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE. Gastrointestinal malignancies: When does race matter? J Am Coll Surg. 2009;209:645–652.CrossRefPubMed Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE. Gastrointestinal malignancies: When does race matter? J Am Coll Surg. 2009;209:645–652.CrossRefPubMed
8.
go back to reference Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer. 2005;5:199–209.CrossRefPubMed Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer. 2005;5:199–209.CrossRefPubMed
9.
go back to reference Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705–1711.CrossRefPubMedPubMedCentral Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705–1711.CrossRefPubMedPubMedCentral
10.
go back to reference van Hooft JE, van Halsema EE, Vanbiervliet G, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2014;46:990–1053.CrossRefPubMed van Hooft JE, van Halsema EE, Vanbiervliet G, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2014;46:990–1053.CrossRefPubMed
Metadata
Title
SEMS for Palliation of Malignant Colonic Obstruction: Why SEMi Available Is Not Good Enough
Author
Christian P. Selinger
Publication date
01-07-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4070-0

Other articles of this Issue 7/2016

Digestive Diseases and Sciences 7/2016 Go to the issue